INTERNATIONAL MUREX TECHNOLOGIES CORP (CIK: 0000864964) EDGAR, Information, Filings... CompaniesBIO.Com

INTERNATIONAL MUREX TECHNOLOGIES CORP

Mailing address
2255 B QUEEN STREET EAST, SUITE 828 TORONTO, ONTARIO, A6
Phone
5198368016
State location
A6
State of incorporation
N/A
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

INTERNATIONAL MUREX TECHNOLOGIES CORP (CIK: 0000864964) is an American company incorporated in the state of A6. Head office is located at 2255 B QUEEN STREET EAST, SUITE 828 TORONTO, ONTARIO, A6. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. INTERNATIONAL MUREX TECHNOLOGIES CORP is a public company and trade via Over-The-Counter (OTC).

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by INTERNATIONAL MUREX TECHNOLOGIES CORP

Filings	Format	Description	Filed/Effective	File/Film Number
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001047469-98-026943 ( Act) Size: KB	Jul-10-1998	000-26144 98664319
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950120-98-000197 ( Act) Size: KB	May-15-1998	000-26144 98623906
8-K	Document	Current report filing Acc-no: 0000902561-98-000164 ( Act) Size: KB	May-01-1998	000-26144 98608127
SC 14D1/A	Document	Acc-no: 0001047469-98-015601 ( Act) Size: KB	Apr-17-1998	005-41252 98596777
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001047469-98-015600 ( Act) Size: KB	Apr-17-1998	005-41252 98596776
SC 14D1/A	Document	Acc-no: 0001047469-98-013446 ( Act) Size: KB	Apr-02-1998	005-41252 98585868
10-K/A	Document	Amendment to Annual report pursuant to section 13 and 15(d) Acc-no: 0000950120-98-000113 ( Act) Size: KB	Mar-31-1998	000-26144 98581664
SC 13D	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001047469-98-011749 ( Act) Size: KB	Mar-26-1998	005-41252 98574722
SC 14D9	Document	Tender offer solicitation / recommendation statements filed under Rule 14d-9 Acc-no: 0001047469-98-010658 ( Act) Size: KB	Mar-20-1998	005-41252 98569476
SC 14D1	Document	Acc-no: 0001047469-98-010655 ( Act) Size: KB	Mar-20-1998	005-41252 98569451
8-K	Document	Current report filing Acc-no: 0000950120-98-000095 ( Act) Size: KB	Mar-18-1998	000-26144 98568568
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0000950120-98-000072 ( Act) Size: KB	Mar-11-1998	000-26144 98561962
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000020405-98-000038 ( Act) Size: KB	Feb-13-1998	005-41252 00000000
S-8	Document	Initial registration statement for securities to be offered to employees pursuant to employee benefit plans Acc-no: 0000950120-98-000018 ( Act) Size: KB	Jan-21-1998	333-44629 98510476
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950120-97-000301 ( Act) Size: KB	Nov-13-1997	000-26144 97716575
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950120-97-000219 ( Act) Size: KB	Aug-11-1997	000-26144 97654965
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000020405-97-000086 ( Act) Size: KB	May-15-1997	005-41252 00000000
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000020405-97-000082 ( Act) Size: KB	May-15-1997	005-41252 00000000
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950120-97-000125 ( Act) Size: KB	May-08-1997	000-26144 97598206
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000020405-97-000066 ( Act) Size: KB	Apr-15-1997	005-41252 00000000

Recent 20 filings. View all INTERNATIONAL MUREX TECHNOLOGIES CORP filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

INTERNATIONAL MUREX TECHNOLOGIES CORP overview
INTERNATIONAL MUREX TECHNOLOGIES CORP job
INTERNATIONAL MUREX TECHNOLOGIES CORP stock
INTERNATIONAL MUREX TECHNOLOGIES CORP ownership
INTERNATIONAL MUREX TECHNOLOGIES CORP CEO
INTERNATIONAL MUREX TECHNOLOGIES CORP documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.